Home › Medivation: A Beaten Down Biotech With Major Growth Potential
 

Keywords :   


Medivation: A Beaten Down Biotech With Major Growth Potential

2015-09-21 19:51:31| Biotech - Topix.net

Note: The prices discussed in the article below reflects the recent 2-for-1 split in the stock price, effective September 16, 2015. Medivation is a commercial and developmental stage biotech company focused on developing treatments for severe, un-met indications.

Tags: major potential growth biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.11 PSA10 () SCR
27.111108
27.11
27.11
27.11SAKEROCK/ 0
27.11Influence THEROW
27.11 A
27.11FIRSTSPEAR
More »